Pedro Ramos has confirmed that the regions Health Authorities will continue to monitor the evolution of the SARS-CoV-2 outbreak on the Corvette António Enes, currently moored in Porto Santo harbour.
Posts tagged as “SARS-CoV-2”
As of today, Madeira moved into the European Centre for Disease Prevention and Control (ECDC) green (low risk) category. Mainland Portugal and the Azores are considered to be at 'moderate risk' (orange).
The continuation of mandatory PCR testing at the airport, and antigen testing on cruise liner passengers was decided at a meeting of the Regional Government Council (PSD/CDS-PP), yesterday, and will come into effect from 00:00 Saturday.
The use of the European digital Covid-19 immunisation certificate, or proof of negative testing comes into force today, and since the 16th of June, more that one million certificates have been issued in Portugal.
Massachusetts biotech company, Moderna, have announced that their SARS-CoV-2 vaccine produces antibodies against the delta variant.
The Doctor Ricardo Jorge National Health Institute (INSA), confirmed today the identification of the Delta variant in Madeira.
Information released today states that free digital Covid-19 certificates should start being issued this week. This provides proof of negative testing, vaccination or recovery from Covid-19.
The President of the Regional Government considers that, even when 70% of the population has been vaccinated, health and safety measures will remain in place in order to keep new strains of the SARS-CoV-2 virus under control.
Miguel Albuquerque admitted to journalists today, that as part of the Regional Governments plan to combat the pandemic, sniffer dogs may be used at the airport to detect passengers infected with the SARS-CoV-2 virus. The idea he said, is still embryonic but would provide a cost effective, workable solution.
Chinese relatives of the first victims of Covid-19 are being pressurised by the Chinese authorities into not talking to any World Health Organisation (WHO) researchers who are currently in Wuhan as part of an investigation into the origin of the SARS-CoV-2 virus.
According to a study published today in the Science Journal, a Spanish drug tested both in France and the United States has shown an almost total reduction in the viral load of the SARS-CoV-2 virus.
The pioneering AT MicroProtect technology to combat Covid-19 and microbiological contamination, developed by a consortium led by BLC3, will be installed, for the first time in the world, at Generis Farmacêutica.
On Tuesday the 15th of December, the United States authorised the marketing of the first test to detect the presence of SARS-CoV-2 by individuals in their own home which provides the results in 20 minutes and does not need a medical prescription.
Results from a study by the Florida University of Health indicate that three antihistamine drugs have shown they have varying degrees of effectiveness in inhibiting cell infection by the SARS-CoV-2 virus. The findings came about after analysing samples in the laboratory and performing a detailed analysis of nearly 250,000 medical patient records from California.